CASCADE BIOCATALYSTS INC.
Cell-free biocatalysts for chemical synthesis and manufacturing
- Sector
- Biotech
- Headquarters
- DENVER, CO
- Founded
- 2022
- Latest Form D
- $5.4M, Aug 2025
- Total capital
- $7M
- Federal grants
- $1.5M
- 2 awards · 2023–2025
- Rank in peer group#1 of 18
- Private capital raised
- $5.4M
- 1 Form D · last Aug 2025
- 14 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$5.4M
- Federal grantNSF · Phase II · SBIR Phase II: Enzyme Stabilization via Immobilization for Advanced Chemical Manufacturing$1.3M
- Federal grantNSF · Phase I · SBIR Phase I: Enzyme Stabilization via Immobilization for Advanced Chemical Manufacturing$275K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
21months
from CASCADE BIOCATALYSTS INC.’s first federal award to its first private round.
- First federal award · Dec 2023
- NSF · $275K
- First Form D · Aug 2025
- $5.4M · 1st Form D
- Awards before first raise
- 2 awards
An association in public records, not a cause or a prediction.
Standing among 18 peers
Line = medianBiotech · Material
- Federal grants#1 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- James WeltzResearcherExecutive Officer, Director, PromoterLinked by $1.5M in grants as PI
- Alexander RosayExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Jared CampbellDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 6- PendingPolymer Brush Compositions Including Chain-end-immobilized Cofactors And Methods For The Production ThereofUSPTOApplication PCTUS2024060407
- PendingChromatographic Media With Multiple Affinities And Methods For The Use And Production ThereofUSPTOApplication PCTUS2024046711
- PendingCompositions Including Co-Immobilized Enzymes and Associated Cofactors and Methods for the Production ThereofUSPTOApplication 63610615
Show all 6 patent records
- Polymer Brush Compositions Including Chain-end-immobilized Cofactors And Methods For The Production ThereofApplication PCTUS2024060407Pending
- Chromatographic Media With Multiple Affinities And Methods For The Use And Production ThereofApplication PCTUS2024046711Pending
- Compositions Including Co-Immobilized Enzymes and Associated Cofactors and Methods for the Production ThereofApplication 63610615Pending
- Chromatographic Media With Multiple Affinities And Methods For The Use And Production ThereofApplication 63582423Pending
- Polymer Brush Compositions Including Chain-End-Immobilized Cofactors and Methods for the Production ThereofApplication 19596993Pending
- Chromatographic Media With Multiple Affinities And Methods For The Use And Production ThereofApplication 19518400Pending
Related companies, and why
- ROCKETML, INC.Similar federal contract value in Biotech · null in contracts
- Proximity Biosciences LLCSimilar federal contract value in Biotech · null in contracts
- Ibex Investment Holdings LLCSimilar federal contract value in Biotech · null in contracts
- ISLEX THERAPEUTICS, LLCSimilar federal contract value in Biotech · null in contracts
- IASO THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- LifEngine Animal Health Laboratories IncorporatedSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .